Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFLDA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,303
Award facts
- Contract value 100% obligated
- $14,303.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,303.48 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on April 23, 2025, with completion scheduled for April 24, 2025. This competitively awarded, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product is being delivered to the company's headquarters location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's comprehensive portfolio of federal contracts demonstrates its capacity to supply a wide range of pharmaceuticals and medical supplies to customers including the Defense Health Agency and U.S. Coast Guard. Dupixent, a specialty medication used to treat various allergic and inflammatory conditions, represents one of many brand-name pharmaceutical products the company delivers through its federal contract vehicles. The delivery order reflects AmerisourceBergen's ongoing role as a primary pharmaceutical supplier within the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FFLDA?
SPE2DB25FFLDA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 23, 2025.
How much is contract SPE2DB25FFLDA worth?
The government has obligated $14,303 on SPE2DB25FFLDA.
Is contract SPE2DB25FFLDA an order under another contract?
Yes. SPE2DB25FFLDA is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFLDA competed?
The extent of competition for SPE2DB25FFLDA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award